![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Plymouth Hospitals NHS Trust |
Information provided by: | Plymouth Hospitals NHS Trust |
ClinicalTrials.gov Identifier: | NCT00225134 |
This study is designed to investigate the use of the somatostatin analogue- Somatuline Autogel in the primary medical treatment of the condition Acromegaly.
Primary Objective: To test the hypothesis that a twelve month period of primary medical treatment of acromegaly with Somatuline Autogel will produce clinically significant reductions in tumour size from Baseline to Month 12 as assessed using MRI.
Condition | Intervention | Phase |
Acromegaly |
Drug: Somatuline Autogel |
Phase III |
MedlinePlus related topics: | Cancer |
ChemIDplus related topics: | Somatostatin Lanreotide acetate |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly |
Estimated Enrollment: | 10 |
Study Start Date: | November 2005 |
![]() |
Show Detailed Description |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients must satisfy all of the following entry criteria before they will be allowed to participate in the study:
Exclusion Criteria:
United Kingdom, Devon | |||||
Dr D Flanagan | Not yet recruiting | ||||
Plymouth, Devon, United Kingdom, PL6 8DH | |||||
Contact: Daniel E Flanagan, MD 44 1752 517578 daniel.flanagan@phnt.swest.nhs.uk | |||||
Principal Investigator: Daniel E Flanagan, MD |
Plymouth Hospitals NHS Trust |
Principal Investigator: | Daniel E Flanagan, MD | Plymouth Hospitals NHS Trust |
Study ID Numbers: | Sponsor Protocol no. AcMed 01 |
First Received: | September 21, 2005 |
Last Updated: | September 21, 2005 |
ClinicalTrials.gov Identifier: | NCT00225134 |
Health Authority: | United Kingdom: National Health Service |
|
|
|
|
|
![]() |